Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | SCN8A | Q9UQD0 | 8/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | LTA4H | P09960 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3296768 | 0.84 | SCN4A (0.38) | ALDH1A1SCN8AKDM4EMEN1KMT2A | |
| SCHEMBL3294491 | 0.83 | CYP1A2 (0.46) | ALDH1A1KDM4ELMNAMAPTNPSR1 | |
| SCHEMBL3295185 | 0.82 | TLR4 (0.36) | MEN1KMT2AMAPTNPSR1LTA4H | |
| SCHEMBL4382775 | 0.82 | ALDH1A1 (0.55) | ALDH1A1SCN8AKDM4EMEN1KMT2A | |
| SCHEMBL3296752 | 0.80 | ALDH1A1 (0.39) | ALDH1A1KDM4ELTA4H | |
| SCHEMBL3297503 | 0.77 | CYP1A2 (0.46) | KDM4EMAPT | |
| SCHEMBL23817559 | 0.76 | ALDH1A1 (0.54) | ALDH1A1SCN8AKDM4EMEN1KMT2A | |
| SCHEMBL6709141 | 0.75 | CYP1A2 (0.52) | ALDH1A1SCN8AKDM4ELMNAMAPT | |
| SCHEMBL3298713 | 0.75 | LMNA (0.40) | ALDH1A1KDM4ELMNAMAPTNPSR1 | |
| SCHEMBL3299989 | 0.74 | ALDH1A1 (0.34) | ALDH1A1SCN8AKDM4ELMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7741393-B2 | Organic silicon-based compound and method of producing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-06-22 | — | — | US | disclosed |
| US-20070203275-A1 | Organic Silicon-Based Compound And Method Of Producing The Same | SUMITOMO CHEMICAL COMPANY, LIMITED | 2007-08-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070203275-A1 | Organic Silicon-Based Compound And Method Of Producing The Same | ARSA, OR10J3, HDAC10 | ALDH1A1 1865/4885SCN8A 1837/4885KDM4E 1578/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.